# Leukotrap WB system - CP2D

NDC: 87069-726
Generic name: CP2D/AS-3 Anticoagulant and Additive System
Labeler / Manufacturer: GVS TM INC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: SOLUTION
Routes: INTRAVENOUS
Marketing started: 20260602

FDA application: BN820915

## Active ingredients

- DEXTROSE, UNSPECIFIED FORM: 3.21 g/63mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"87069-726"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=87069-726
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=42ece7e1-1da1-7e5a-e063-6294a90ac803